β-Blocking and racial variation in the severity of retinopathy of prematurity.
Smith-Kettlewell Eye Research Institute, San Francisco, CA 94115, USA. good@ski.org
William V
WV
Good
Robert J
RJ
Hardy
David K
DK
Wallace
Don
D
Bremer
David L
DL
Rogers
R Michael
RM
Siatkowski
Inge
I
De Becker
C Gail
CG
Summers
Rae
R
Fellows
Betty
B
Tung
Earl A
EA
Palmer
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D001741:Black or African American; D018450:Disease Progression; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D011110:Polymorphism, Genetic; D011943:Receptors, Adrenergic, beta / Q000235:genetics; D012178:Retinopathy of Prematurity / Q000208:ethnology / Q000503:physiopathology* / Q000517:prevention & control; D044465:White People
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta